EFFICACY OF REVEFENACIN, A LONG-ACTING MUSCARINIC ANTAGONIST FOR NEBULIZED THERAPY, IN COPD PATIENTS WITH MARKERS OF MORE SEVERE DISEASEJames F. Donohue,Edward Kerwin,Chris Barnes, Edmund Moran,Brett Haumann,Srikanth Pendyala,Glenn CraterCHEST(2018)引用 2|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要